Alan Kozikowski
Plus aucun poste en cours
Fortune : 436 545 $ au 30/04/2024
Profil
Alan P.
Kozikowski was the founder of Actuate Therapeutics, Inc. (founded in 2015) and Bright Minds Biosciences, Inc. (founded in 2019), where he held the title of Director in 2022.
He was the President & Chief Executive Officer of Starwise Therapeutics LLC from 2017 to 2020.
He also held the title of Director-Drug Discovery Program at Georgetown University Medical Center and was a Professor at the University of Pittsburgh.
From 2013 to 2017, he was a Professor-Emeritus at the University of Illinois.
Détentions connues dans des sociétés publiques
| Société | Date | Nombre d'actions | Valorisation | Date de valorisation |
|---|---|---|---|---|
| 22/12/2023 | 400 500 ( 9,27% ) | 436 545 $ | 30/04/2024 |
Anciens postes connus de Alan Kozikowski
| Sociétés | Poste | Fin |
|---|---|---|
| BRIGHT MINDS BIOSCIENCES INC. | Fondateur | 07/09/2022 |
| Starwise Therapeutics LLC | Directeur Général | 01/02/2020 |
| University of Illinois | Corporate Officer/Principal | 31/07/2017 |
Actuate Therapeutics, Inc.
 Actuate Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Actuate Therapeutics, Inc. is a clinical stage biopharmaceutical company, which engages in developing therapeutics which target cancers and neurodegenerative diseases. It offers treatment for cancer and inflammatory diseases. It focuses on developing elraglusib. The company was founded by Andrew P. Mazar on January 16, 2015 and is headquartered in Fort Worth, TX. | Fondateur | - |
| Georgetown University Medical Center | Corporate Officer/Principal | - |
Expériences
Fonctions occupées
Relations
Relations au 1er degré
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Sociétés cotées | 1 |
|---|---|
| BRIGHT MINDS BIOSCIENCES INC. | Health Technology |
| Entreprise privées | 2 |
|---|---|
Actuate Therapeutics, Inc.
Actuate Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Actuate Therapeutics, Inc. is a clinical stage biopharmaceutical company, which engages in developing therapeutics which target cancers and neurodegenerative diseases. It offers treatment for cancer and inflammatory diseases. It focuses on developing elraglusib. The company was founded by Andrew P. Mazar on January 16, 2015 and is headquartered in Fort Worth, TX. | Health Technology |
| Starwise Therapeutics LLC |